Target intelligence / Profile preview

Superoxide dismutase and catalase system (SOD/CAT)

Target
SOD/CAT
Molecular classification
Enzyme, Oxidoreductase, Antioxidant
01

Overview

The superoxide dismutase (SOD) and catalase (CAT) systems represent the primary enzymatic defense network against reactive oxygen species (ROS) in aerobic organisms [Ighodaro & Akinloye, 2018]. SOD enzymes (including SOD1, SOD2, and SOD3) catalyze the dismutation of superoxide radicals into hydrogen peroxide and oxygen, while catalase subsequently decomposes hydrogen peroxide into water and oxygen [UniProt P00441, P04040]. This coordinated activity is essential for protecting cellular components such as DNA, proteins, and lipids from oxidative damage. Mutations in SOD1 are famously associated with familial amyotrophic lateral sclerosis (ALS), underscoring the system's critical role in neuroprotection [Rosen et al., 1993]. Therapeutic strategies focus on using SOD mimetics (e.g., avasopasem manganese) or synthetic SOD/catalase dual-function compounds (e.g., EUK-134) to mitigate oxidative stress in conditions like ischemia-reperfusion injury, radiation-induced tissue damage, and chronic inflammation [Day, 2009; Galera Therapeutics]. However, because ROS also function as vital signaling molecules, pharmacological modulation of these systems must be carefully balanced to avoid disrupting normal physiological processes.

Other names
SOD-CAT systemAntioxidant enzyme systemSuperoxide:superoxide oxidoreductase and hydrogen-peroxide:hydrogen-peroxide oxidoreductase
02

Mechanism of action

Catalytic scavenging of superoxide anions and hydrogen peroxide to prevent oxidative damage and restore redox balance.

03

Biological functions

Redox homeostasisOxidative stress protectionReactive oxygen species scavengingRedox signaling
04

Disease associations

Amyotrophic lateral sclerosisCardiovascular diseaseIschemia-reperfusion injuryCancerNeurodegenerative diseaseInflammation
05

Safety considerations

Interference with physiological ROS-mediated signalingPotential pro-oxidant effects under specific conditionsImmunogenicity of non-human enzyme-based therapiesDelivery and stability challenges for synthetic mimetics
06

Interacting drugs

Avasopasem manganese

5 more in the full profile.

07

Biomarkers

Superoxide dismutase activityCatalase activityMalondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonyls

Beyond the preview

Go deeper on Superoxide dismutase and catalase system (SOD/CAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superoxide dismutase and catalase system (SOD/CAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call